U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Partial anomalous pulmonary venous return

MedGen UID:
450995
Concept ID:
C0158634
Congenital Abnormality
Synonyms: congenital partial pulmonary venous return anomaly; Congenital partial pulmonary venous return anomaly; PAPVC - Partial anomalous pulmonary venous connection; PAPVD - Partial anomalous pulmonary venous drainage; PAPVR - Partial anomalous pulmonary venous return; Partial anomalous pulmonary venous connection; Partial anomalous pulmonary Venous connection; Partial Anomalous Pulmonary Venous Return; Partial anomalous pulmonary Venous return
SNOMED CT: Partial anomalous pulmonary venous connection (68237008); Partial anomalous pulmonary venous return (68237008); PAPVD - Partial anomalous pulmonary venous drainage (68237008); PAPVC - Partial anomalous pulmonary venous connection (68237008); PAPVR - Partial anomalous pulmonary venous return (68237008)
 
HPO: HP:0010773
Monarch Initiative: MONDO:0020453
Orphanet: ORPHA99124

Definition

A form of anomalous pulmonary venous return in which not all pulmonary veins drain abnormally. Partial anomalous pulmonary venous return frequently involves one or both of the veins from one lung. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPartial anomalous pulmonary venous return

Conditions with this feature

Down syndrome
MedGen UID:
4385
Concept ID:
C0013080
Disease or Syndrome
Down syndrome, the most frequent form of mental retardation caused by a microscopically demonstrable chromosomal aberration, is characterized by well-defined and distinctive phenotypic features and natural history. It is caused by triplicate state (trisomy) of all or a critical portion of chromosome 21.
Langer-Giedion syndrome
MedGen UID:
6009
Concept ID:
C0023003
Disease or Syndrome
Trichorhinophalangeal syndrome (TRPS) comprises TRPS I (caused by a heterozygous pathogenic variant in TRPS1) and TRPS II (caused by a contiguous gene deletion of TRPS1, RAD21, and EXT1). Both TRPS types are characterized by distinctive facial features (large nose with broad nasal ridge and tip and underdeveloped alae; thick and broad medial eyebrows; long philtrum; thin vermilion of the upper lip; and large prominent ears); ectodermal features (fine, sparse, depigmented, and slow-growing hair and dystrophic nails); and skeletal findings (short stature, brachydactyly with ulnar or radial deviation of the fingers, short feet, and early, marked hip dysplasia). TRPS II is additionally characterized by multiple osteochondromas and an increased risk of mild-to-moderate intellectual disability.
Cholestasis-pigmentary retinopathy-cleft palate syndrome
MedGen UID:
208652
Concept ID:
C0795969
Disease or Syndrome
MED12-related disorders include the phenotypes of FG syndrome type 1 (FGS1), Lujan syndrome (LS), X-linked Ohdo syndrome (XLOS), Hardikar syndrome (HS), and nonspecific intellectual disability (NSID). FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and abnormalities of the corpus callosum. FGS1 is further characterized by absolute or relative macrocephaly, tall forehead, downslanted palpebral fissures, small and simple ears, constipation and/or anal anomalies, broad thumbs and halluces, and characteristic behavior. LS is further characterized by large head, tall thin body habitus, long thin face, prominent nasal bridge, high narrow palate, and short philtrum. Carrier females in families with FGS1 and LS are typically unaffected. XLOS is characterized by intellectual disability, blepharophimosis, and facial coarsening. HS has been described in females with cleft lip and/or cleft palate, biliary and liver anomalies, intestinal malrotation, pigmentary retinopathy, and coarctation of the aorta. Developmental and cognitive concerns have not been reported in females with HS. Pathogenic variants in MED12 have been reported in an increasing number of males and females with NSID, with affected individuals often having clinical features identified in other MED12-related disorders.
Meacham syndrome
MedGen UID:
373234
Concept ID:
C1837026
Disease or Syndrome
WT1 disorder is characterized by congenital/infantile or childhood onset of steroid-resistant nephrotic syndrome (SRNS), a progressive glomerulopathy that does not respond to standard steroid therapy. Additional common findings can include disorders of testicular development (with or without abnormalities of the external genitalia and/or müllerian structures) and Wilms tumor. Less common findings are congenital anomalies of the kidney and urinary tract (CAKUT) and gonadoblastoma. While various combinations of renal and other findings associated with a WT1 pathogenic variant were designated as certain syndromes in the past, those designations are now recognized to be part of a phenotypic continuum and are no longer clinically helpful.
Alveolar capillary dysplasia with pulmonary venous misalignment
MedGen UID:
755478
Concept ID:
C2960310
Congenital Abnormality
Congenital alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is characterized histologically by failure of formation and ingrowth of alveolar capillaries that then do not make contact with alveolar epithelium, medial muscular thickening of small pulmonary arterioles with muscularization of the intraacinar arterioles, thickened alveolar walls, and anomalously situated pulmonary veins running alongside pulmonary arterioles and sharing the same adventitial sheath. Less common features include a reduced number of alveoli and a patchy distribution of the histopathologic changes. The disorder is associated with persistent pulmonary hypertension of the neonate and shows varying degrees of lability and severity (Boggs et al., 1994). Affected infants present with respiratory distress resulting from pulmonary hypertension in the early postnatal period, and the disease is uniformly fatal within the newborn period (Vassal et al., 1998). Additional features of ACDMPV include multiple congenital anomalies affecting the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems, as well as disruption of the normal right-left asymmetry of intrathoracic or intraabdominal organs (Sen et al., 2004).
Heterotaxy, visceral, 5, autosomal
MedGen UID:
501198
Concept ID:
C3495537
Congenital Abnormality
Heterotaxy ('heter' meaning 'other' and 'taxy' meaning 'arrangement'), or situs ambiguus, is a developmental condition characterized by randomization of the placement of visceral organs, including the heart, lungs, liver, spleen, and stomach. The organs are oriented randomly with respect to the left-right axis and with respect to one another (Srivastava, 1997). Heterotaxy is a clinically and genetically heterogeneous disorder. For a discussion of genetic heterogeneity of visceral heterotaxy, see HTX1 (306955).
Structural heart defects and renal anomalies syndrome
MedGen UID:
1387412
Concept ID:
C4479549
Disease or Syndrome
Cardiac-urogenital syndrome
MedGen UID:
1648333
Concept ID:
C4748946
Disease or Syndrome
MYRF-related cardiac urogenital syndrome (MYRF-CUGS) is primarily characterized by anomalies of the internal and external genitalia, congenital heart defects, and eye anomalies. 46,XY individuals can have a range of anomalies of the genitalia, from isolated unilateral cryptorchidism to ambiguous genitalia to typical-appearing female genitalia. 46,XX individuals can have atypical internal genitalia including absent uterus, absent fallopian tubes, small or absent ovaries, absent vagina, or blind-ending vagina. A number of congenital heart defects have been described, with scimitar syndrome being the most common. Eye issues, present in a vast majority of affected individuals, include high hyperopia and nanophthalmos (an ocular malformation featuring short axial length due to small anterior and posterior segments with thickened choroid and sclera and normal lens volume). Because of the common nature of the eye anomalies, it has been suggested that this condition may be more accurately referred to as "MYRF-related ocular cardiac urogenital syndrome." Other features of the condition include a broad range of developmental delay /intellectual disability (DD/ID), from typical development and cognition to severe DD/ID; pulmonary abnormalities and diaphragmatic issues (congenital diaphragmatic hernia / diaphragmatic eventration); intestinal malrotation; and mild growth and feeding problems.
Developmental and epileptic encephalopathy, 85, with or without midline brain defects
MedGen UID:
1708832
Concept ID:
C5393312
Disease or Syndrome
Developmental and epileptic encephalopathy-85 with or without midline brain defects (DEE85) is an X-linked neurologic disorder characterized by onset of severe refractory seizures in the first year of life, global developmental delay with impaired intellectual development and poor or absent speech, and dysmorphic facial features. The seizures tend to show a cyclic pattern with clustering. Many patients have midline brain defects on brain imaging, including thin corpus callosum and/or variable forms of holoprosencephaly (HPE). The severity and clinical manifestations are variable. Almost all reported patients are females with de novo mutations predicted to result in a loss of function (LOF). However, some patients may show skewed X inactivation, and the pathogenic mechanism may be due to a dominant-negative effect. The SMC1A protein is part of the multiprotein cohesin complex involved in chromatid cohesion during DNA replication and transcriptional regulation; DEE85 can thus be classified as a 'cohesinopathy' (summary by Symonds et al., 2017 and Kruszka et al., 2019). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Congenital heart defects, multiple types, 8, with or without heterotaxy
MedGen UID:
1794252
Concept ID:
C5562042
Disease or Syndrome
Multiple types of congenital heart defects-8 (CHTD8) is characterized by cardiac septal defects, double-outlet right ventricle, unbalanced complete atrioventricular canal, and valvular anomalies, as well as vascular anomalies including dextroposition of the great arteries, anomalous pulmonary venous return, and superior vena cava to left atrium defect. Patients may also exhibit laterality defects, including dextrocardia, atrial isomerism, dextrogastria, left-sided gallbladder, and intestinal malrotation (Zaidi et al., 2013; Granadillo et al., 2018).
Chromosome 1p36 deletion syndrome, proximal
MedGen UID:
1794324
Concept ID:
C5562114
Disease or Syndrome
Proximal 1p36 deletion syndrome is a multisystem developmental disorder characterized by global developmental delay with impaired intellectual development, poor overall growth with microcephaly, axial hypotonia, and dysmorphic facial features. Most patients have congenital cardiac malformations or cardiac dysfunction. Additional more variable features may include distal skeletal anomalies, seizures, and cleft palate. The phenotype shows some overlap with distal chromosome 1p36 deletion syndrome (summary by Kang et al., 2007).
Heterotaxy, visceral, 12, autosomal
MedGen UID:
1803695
Concept ID:
C5676898
Congenital Abnormality
Visceral heterotaxy-12 (HTX12) is an embryonic developmental disorder characterized by defects in the asymmetric positioning of visceral organs across the left-right axis, known as laterality defects. The phenotype is highly variable, ranging from complete organ reversal (situs inversus totalis) to selective misarrangement of organs (situs ambiguus) such as the liver, spleen, and pancreas. The disorder is often associated with dextrocardia or variable complex congenital heart defects. Early death may occur in the most severe cases (summary by Szenker-Ravi et al., 2022). For a discussion of the genetic heterogeneity of visceral heterotaxy, see HTX1 (306955).

Professional guidelines

PubMed

Holt DB, Moller JH, Larson S, Johnson MC
Am J Cardiol 2007 Feb 15;99(4):568-72. Epub 2007 Jan 2 doi: 10.1016/j.amjcard.2006.09.100. PMID: 17293205

Recent clinical studies

Etiology

Gözgeç E, Kantarci M, Guven F, Ogul H, Ceviz N, Eren S
Folia Morphol (Warsz) 2021;80(2):336-343. Epub 2020 May 27 doi: 10.5603/FM.a2020.0054. PMID: 32459365
Cherian SV, Kumar A, Ocazionez D, Estrada-Y-Martin RM, Restrepo CS
Respir Med 2019 Aug;155:86-96. Epub 2019 Jul 11 doi: 10.1016/j.rmed.2019.07.011. PMID: 31326738
Olsen R, Doyle Z, Levy D, Anton T, Molkara D, Tarsa M, Sklansky M, Pretorius DH
J Ultrasound Med 2016 Jun;35(6):1193-206. Epub 2016 Apr 28 doi: 10.7863/ultra.15.04041. PMID: 27126401
Fukamizu S, Sakurada H, Nishizaki M, Hiraoka M
Heart Rhythm 2012 Jun;9(6):1002-3. Epub 2011 Feb 19 doi: 10.1016/j.hrthm.2011.02.017. PMID: 21338714
Robicsek F, Daugherty HK, Cook JW, Selle JG
J Thorac Cardiovasc Surg 1979 Oct;78(4):559-62. PMID: 480963

Diagnosis

Esparza-Jiménez-Morán M, Corona-Villalobos C, Cano-Zárate R, Pérez-Juárez F, Bobadilla-Aguirre A
Arch Cardiol Mex 2024 Mar 15;94(3):381-384. doi: 10.24875/ACM.23000263. PMID: 38489030Free PMC Article
Nsahlai M, Telmesani A, Duarte VE
Methodist Debakey Cardiovasc J 2022;18(1):96-101. Epub 2022 Oct 4 doi: 10.14797/mdcvj.1124. PMID: 36304792Free PMC Article
Bhalla JS, van Zyl M, Madhavan M
Europace 2022 Oct 13;24(9):1459. doi: 10.1093/europace/euac006. PMID: 35357427
Chang CC, Lin CY
Radiology 2022 Mar;302(3):513. Epub 2021 Nov 23 doi: 10.1148/radiol.2021212103. PMID: 34812673
Fraile Olivero CA, Pardina Solano MA, Milla Collado L
Arch Bronconeumol 2021 Nov;57(11):703. Epub 2021 Sep 9 doi: 10.1016/j.arbr.2021.09.004. PMID: 35699012

Therapy

Tarca A, Woo N, Bain S, Crouchley D, McNulty E, Yim D
Heart Lung Circ 2023 Dec;32(12):1443-1450. Epub 2023 Nov 25 doi: 10.1016/j.hlc.2023.09.021. PMID: 38007317
Dallapellegrina L, Sciatti E, Vizzardi E, Metra M
J Cardiovasc Med (Hagerstown) 2021 Dec 1;22(12):e15-e17. doi: 10.2459/JCM.0000000000001205. PMID: 34747929
Hongu H, Yamagishi M, Maeda Y, Itatani K, Asada S, Fujita S, Yaku H
J Thorac Cardiovasc Surg 2019 May;157(5):1970-1977. Epub 2019 Jan 26 doi: 10.1016/j.jtcvs.2019.01.057. PMID: 30824350
Habito CM, Kalva SP
J Vasc Interv Radiol 2012 Mar;23(3):369. Epub 2012 Jan 25 doi: 10.1016/j.jvir.2011.11.011. PMID: 22277274
Levy JM, Smyth SH
J Vasc Interv Radiol 2002 Apr;13(4):423-5. doi: 10.1016/s1051-0443(07)61748-5. PMID: 11932376

Prognosis

Sulaiman S, Nair RG
Cardiol Young 2017 Aug;27(6):1216-1218. Epub 2017 May 25 doi: 10.1017/S1047951117000956. PMID: 28539136
Habito CM, Kalva SP
J Vasc Interv Radiol 2012 Mar;23(3):369. Epub 2012 Jan 25 doi: 10.1016/j.jvir.2011.11.011. PMID: 22277274
Fukamizu S, Sakurada H, Nishizaki M, Hiraoka M
Heart Rhythm 2012 Jun;9(6):1002-3. Epub 2011 Feb 19 doi: 10.1016/j.hrthm.2011.02.017. PMID: 21338714
Banerji D, Martinez F, Abbara S, Truong QA
J Cardiovasc Comput Tomogr 2011 May-Jun;5(3):189-91. Epub 2011 Jan 28 doi: 10.1016/j.jcct.2011.01.008. PMID: 21376695Free PMC Article
Robicsek F, Daugherty HK, Cook JW, Selle JG
J Thorac Cardiovasc Surg 1979 Oct;78(4):559-62. PMID: 480963

Clinical prediction guides

Egbe AC, Younis A, Ali AE, Karnakoti S, Stephens EH, Dearani JA, Francois C, Connolly HM
J Am Heart Assoc 2024 Sep 3;13(17):e036403. Epub 2024 Aug 27 doi: 10.1161/JAHA.124.036403. PMID: 39189474Free PMC Article
Ellouze N, Farhat N, Desprechins B, Seghaye MC
Acta Cardiol 2017 Aug;72(4):489-490. Epub 2017 Jul 14 doi: 10.1080/00015385.2017.1310800. PMID: 28705051
Gutmark-Little I, Hor KN, Cnota J, Gottliebson WM, Backeljauw PF
J Pediatr Endocrinol Metab 2012;25(5-6):435-40. doi: 10.1515/jpem-2012-0046. PMID: 22876535
Habito CM, Kalva SP
J Vasc Interv Radiol 2012 Mar;23(3):369. Epub 2012 Jan 25 doi: 10.1016/j.jvir.2011.11.011. PMID: 22277274
Banerji D, Martinez F, Abbara S, Truong QA
J Cardiovasc Comput Tomogr 2011 May-Jun;5(3):189-91. Epub 2011 Jan 28 doi: 10.1016/j.jcct.2011.01.008. PMID: 21376695Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...